tivozanib hydrochloride
(ty-VOH-zuh-nib HY-droh-KLOR-ide)
A drug used to treat adults with advanced renal cell carcinoma (a type of kidney cancer). It is used in patients whose cancer has relapsed (come back) or has not gotten better after treatment with at least two other types of systemic therapy. It is also being studied in the treatment of other types of cancer. Tivozanib hydrochloride blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Tivozanib hydrochloride is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called Fotivda.